FARMINGTON, Conn.--(BUSINESS WIRE)--Today, scientists from Applied Biosystems (NYSE:ABI) will present data at the Connecticut Stem Cell Technology Symposium revealing how the company’s ultra-high-throughput genomic analysis platform, the SOLiD™ System, generated genome-wide expression profiling data at the single cell level. Gene expression signatures at the single cell level have the potential to reveal details about cell fate and will potentially accelerate the discovery of biomarkers for disease. This finding represents the first use of a genomic analysis platform for a hypothesis-neutral, genome-wide survey of expressed genes in individual cells.
